Focus on Pradaxa

Pradaxa® is the name under which Boehringer Ingelheim Pharmaceuticals, Inc. markets a prescription anticoagulant medication generically called dabigatran.

_______________________________________________________________________________

Free Pradaxa Case Evaluation

The information you provide to us for this Free Case Evaluation will be treated as strictly confidential.  You will get a reply from us no later than the next business day.  Submitting a case evaluation does not obligate you to hire our law firm for your lawsuit.  We handle all cases on a contingency fee basis, which means that you will make no payment for our legal services until after we have succeeded in getting legal compensation for you.

_______________________________________________________________________________

My Articles About Pradaxa

Drug Injury Watch: Blood Thinner Pradaxa Linked To More Cases Of Serious Bleeding Events And New FDA Study Confirms Increased Risk Of GI Bleeds Compared To Warfarin

More Than 2000 Pradaxa Lawsuits Have Been Filed Against Boehringer, And A Company Official Has Admitted That More Than 1400 Patients Bled To Death

SUMMARY:  In May 2014 it was reported that a new analysis of a company-funded study of 18,000-patients, known as RE-LY — which the drug company Boehringer Ingelheim used to win FDA approval of its controversial blood thinner Pradaxa — turned up 22 “new” serious bleeding events that were not included in the original study report.

Also in May 2014 the FDA issued a follow-up to its Pradaxa Drug Safety Communication issued on November 2, 2012, and the FDA has reiterated that Pradaxa is associated with an increased risk of major gastrointestinal (GI) bleeding compared to warfarin.

We will continue to monitor the safety issues surrounding Pradaxa, especially those involving cases of gastrointestinal (GI) bleeding adverse drug events.

[Read this article in full at original source]

Earlier Pradaxa articles by Tom Lamb on the Drug Injury Watch blog:

Drug Injury Watch: FDA Drug Safety Concerns About Pradaxa And Serious Bleeding Side Effects Will Get Another Look By Means Of New 2014 Study

Drug Injury Watch: The Pradaxa Gastrointestinal (GI) Bleeding Debate Continues: Is There An Increased Risk Or A Risk Reduction With Pradaxa Use?

Drug Injury Watch: Pradaxa Adverse Drug Events (ADEs) Result In Death More Often Than Other Anticoagululants / Blood Thinners ADE Reports

Drug Injury Watch: Pradaxa: February 2013 Update: Federal Court MDL Litigation Now Involves About 200 Lawsuits

Drug Injury Watch: December 2012 Pradaxa Label Change: Contraindication: Use By Mechanical Heart Valves Patients

Drug Injury Watch: December 2012 Pradaxa Update: Prescription / Sales Numbers And Drug Company Safety Study Results

Drug Injury Watch: Pradaxa Safety Debate Continues During November 2012 With Many Different Conclusions And Positions

Drug Injury Watch: Fall 2012: Two Recent Medical Reports Regarding Safety Of Pradaxa, Boehringer Ingelheim’s Anticoagulation Drug

Drug Injury Watch: Increasing Number Of Pradaxa Lawsuits Against Boehringer Are Consolidated In Federal Court MDL

Drug Injury Watch: Pradaxa Side Effects Update Mid-2012: Deaths, Hemorrhages, Acute Renal Failure, and Stroke Events Submitted To FDA MedWatch

Drug Injury Watch: Safety Developments Regarding Pradaxa: Boehringer Starts Drug Registry; EMA Wants Label Change; Study Compares Pradaxa Use To Coumadin As Regards Side Effects

Drug Injury Watch: Pradaxa Noted For Possible Heart Attack Risk In Addition To Serious Gastrointestinal Bleeding And Other Hemorrhages

Drug Injury Watch: Pradaxa Hemorrhage Cases May Occur In Oldest Patients Due To Age-Related Decline In Renal Function

Drug Injury Watch: Pradaxa: 2012 Label Revisions In The U.S. And Canada, Where A “Dear Doctor” Letter Was Sent Out

Drug Injury Watch: Pradaxa Bleeding Events: Four Major Factors Which Contributed To These Serious Side Effects

Drug Injury Watch: Pradaxa: Excess Number Of Severe Bleeding Events In Certain Patient Populations And Settings

Drug Injury Watch: Safety Profile Of New Stroke Drug Pradaxa Has Been Tarnished By Various Adverse Event Reports  

Drug Injury Watch: Pradaxa: FDA Investigating Possible Higher Than Expected Incident Rate Of Serious Bleeding Side Effects  

Drug Injury Watch: New Heart Drug Pradaxa May Be Sending “Early” Drug Safety Signals

_____________________________________________________________________________

News Regarding Pradaxa

Boehringer Pays $650 Million to End Blood Thinner Cases

FDA: Don’t Use Pradaxa Blood Thinner in Patients With Artificial Heart Valve

Boehringer Sued by Hundreds Over Bleeding Tied to Pradaxa

A Promising Drug With a Flaw

Article Says Agency Let Risky Drugs Hit Market

Nashville heart doctors react to Pradaxa reports

EMA Recommends Patient, Prescriber Information For Pradaxa Be Updated

Pradaxa Patients Can’t Stop the Bleeding

Boehringer’s Pradaxa website censured

Death magnifies Pradaxa hemorrhage concerns

Heart attack risk seen with clot drug Pradaxa 

Boehringer says about 260 deaths related to Pradaxa  

Boehringer says about 50 deaths related to Pradaxa  

_______________________________________________________________________________

More About Pradaxa At
Our DrugInjuryLaw.com Web Site

Visit the Pradaxa Information page at our Drug Injury Law web site for up-to-the-date developments regarding personal injury and wrongful death lawsuits that involve Pradaxa.

The Law Offices of Thomas J. Lamb, P.A. is handling personal injury and wrongful death lawsuits against the drug company when any of these medical conditions developed while using Pradaxa:

• Serious Bleeding Events
• Hemorrhages
• Heart Attack or Myocardial Infarction (MI)
• Acute Coronary Syndrome (ACS)

If you or someone you know is interested in filing a claim for legal compensation, we offer a free Case Evaluation online at our Drug Injury Law web site.

In the alternative, you can call our toll-free number, (800) 426-9535, to discuss a possible Pradaxa case with attorney Tom Lamb.

______________________________________________________________________________

DrugInjuryLaw.com: Legal Information And News About Prescription Drug Side Effects ______________________________________________________________________________